You are currently viewing a new version of our website. To view the old version click .

Pharmaceutics, Volume 5, Issue 1

March 2013 - 12 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (12)

  • Review
  • Open Access
62 Citations
8,704 Views
19 Pages

As versatile drug delivery systems, polymeric micelles have demonstrated particular strength in solubilizing hydrophobic anticancer drugs while eliminating the use of toxic organic solvents and surfactants. However, the true promise of polymeric mice...

  • Article
  • Open Access
25 Citations
9,473 Views
22 Pages

Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan Statistic

  • Jeffrey S. Brown,
  • Kenneth R. Petronis,
  • Andrew Bate,
  • Fang Zhang,
  • Inna Dashevsky,
  • Martin Kulldorff,
  • Taliser R. Avery,
  • Robert L. Davis,
  • K. Arnold Chan and
  • Susan E. Andrade
  • + 8 authors

Background: Drug adverse event (AE) signal detection using the Gamma Poisson Shrinker (GPS) is commonly applied in spontaneous reporting. AE signal detection using large observational health plan databases can expand medication safety surveillance. M...

  • Commentary
  • Open Access
10 Citations
6,097 Views
11 Pages

Since the late 1990s, there have been tremendous strides made in improving the capacity for carrying out routine active surveillance of new vaccines in the United States. These strides have led to new surveillance systems that are now in place. Some...

  • Review
  • Open Access
117 Citations
17,129 Views
41 Pages

8 February 2013

Neurodegenerative diseases represent a major public health problem, but beneficial clinical treatment with neurotrophic factors has not been established yet. The therapeutic use of neurotrophins has been restrained by their instability and rapid degr...

  • Article
  • Open Access
7 Citations
7,571 Views
12 Pages

5 February 2013

The analysis of nanomaterials in pharmaceutical or cosmetic preparations is an important aspect both in formulation development and quality control of marketed products. Despite the increased popularity of nanoparticulate compounds especially in derm...

  • Communication
  • Open Access
40 Citations
11,510 Views
8 Pages

25 January 2013

The Nano Spray Dryer B-90 offers a new, simple, and alternative approach for the production of drug nanocrystals. In this study, the preparation of steroid nanocrystals using the Nano Spray Dryer B-90 was demonstrated. The particle size was controlle...

  • Article
  • Open Access
69 Citations
15,123 Views
13 Pages

Safety Monitoring in Clinical Trials

  • Bin Yao,
  • Li Zhu,
  • Qi Jiang and
  • H. Amy Xia

Monitoring patient safety during clinical trials is a critical component throughout the drug development life-cycle. Pharmaceutical sponsors must work proactively and collaboratively with all stakeholders to ensure a systematic approach to safety mon...

  • Article
  • Open Access
20 Citations
10,815 Views
12 Pages

Correlating Physicochemical Properties of Boronic Acid-Chitosan Conjugates to Glucose Adsorption Sensitivity

  • Yaa Asantewaa,
  • Jonathan Aylott,
  • Jonathan C. Burley,
  • Nashiru Billa and
  • Clive J. Roberts

Phenyl boronic acid (PBA), which is known to interact with glucose, was covalently bonded to chitosan by direct reductive N-alkylation of chitosan with 4-formylphenylboronic acid (4-FPBA). Evidence of PBA bonding on chitosan was assessed by FTIR, ToF...

  • Article
  • Open Access
16 Citations
9,818 Views
13 Pages

Pharmacokinetic Evaluation of a DSPE-PEG2000 Micellar Formulation of Ridaforolimus in Rat

  • Connie M. Remsberg,
  • Yunqi Zhao,
  • Jody K. Takemoto,
  • Rebecca M. Bertram,
  • Neal M. Davies and
  • Marcus Laird Forrest

The rapamycin analog, ridaforolimus, has demonstrated potent anti-proliferative effects in cancer treatment, and it currently is being evaluated in a range of clinical cancer studies. Ridaforolimus is an extremely lipophilic compound with limited aqu...

  • Article
  • Open Access
4 Citations
7,164 Views
13 Pages

This study investigated the effects of nitrate on bone mineral density (BMD) and bone marrow perfusion in ovariectomized (OVX) female rats, and also the effects of nitrate on in vitro osteoblastic activity and osteoclastic differentiation of murine m...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceutics - ISSN 1999-4923